
Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y 12 Receptor Inhibitors With and Without Aspirin: Results of the VORA ‐ PRATIC Study
Author(s) -
Franchi Francesco,
Rollini Fabiana,
Faz Gabriel,
Rivas Jose Ramon,
Rivas Andrea,
Agarwal Malhar,
Briceno Maryuri,
Wali Mustafa,
Nawaz Ahmed,
Silva Gabriel,
Shaikh Zubair,
Maaliki Naji,
Fahmi Kerolos,
Been Latonya,
Pineda Andres M.,
Suryadevara Siva,
Soffer Daniel,
Zenni Martin M.,
Baber Usman,
Mehran Roxana,
Jennings Lisa K.,
Bass Theodore A.,
Angiolillo Dominick J.
Publication year - 2020
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.120.015865
Subject(s) - medicine , aspirin , ticagrelor , pharmacodynamics , myocardial infarction , pharmacology , p2y12 , cangrelor , cardiology , clopidogrel , pharmacokinetics